← Leaderboards
Mark M Fuster
Va San Diego Healthcare System
$1,176,960
Attributed
$1,176,960
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300.5K · FY2011–25$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,176,960 · 1
VA$0 · 2
By mechanism
R01$1,176,960 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Heparitin Sulfate”
- Jeffrey D Esko · University Of California San Diego$17,527,370
- Pyong Woo Park · Baylor College Of Medicine$14,878,527
- Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute$12,341,999
- Vincent C. Hascall · Cleveland Clinic Foundation$11,439,932
- Jian None Liu · University Of North Carolina Chapel Hill$9,367,049
- Lianchun Wang · University Of Georgia$8,970,811
Research focus
Heparitin SulfateGeneticPolysaccharidesCellsDendritic CellsLymphatic EndotheliumMediatingMutationLymphaticImmuneProteoglycanSugarAntigensT Cell ResponsePathway InteractionsTumorAutomobile DrivingStructureIn VivoLymphatic Endothelial CellsMalignant Neoplasm Of LungCarcinomaBaseAnabolism
Grant awards (14)
Glycocalyx Targeting and Augmenting Cellular Immunity in Lung Cancer$0
I01 · FY2025 · VA · contact PI
Glycocalyx Targeting and Augmenting Cellular Immunity in Lung Cancer$0
I01 · FY2024 · VA · contact PI
Glycocalyx Targeting and Augmenting Cellular Immunity in Lung Cancer$0
I01 · FY2023 · VA · contact PI
Glycocalyx Targeting and Augmenting Cellular Immunity in Lung Cancer$0
I01 · FY2022 · VA · contact PI
Dendritic Cell Proteoglycans and Reprogramming Cancer Immunity$0
I01 · FY2021 · VA · contact PI
Dendritic Cell Proteoglycans and Reprogramming Cancer Immunity$0
I01 · FY2020 · VA · contact PI
Dendritic Cell Proteoglycans and Reprogramming Cancer Immunity$0
I01 · FY2019 · VA · contact PI
Dendritic Cell Proteoglycans and Reprogramming Cancer Immunity$0
I01 · FY2018 · VA · contact PI
Lymphatic Microenvironment: Altering Cell Traffic by Targeting Glycans$295,967
R01 · FY2015 · HL · contact PI
Lymphatic Microenvironment: Altering Cell Traffic by Targeting Glycans$294,466
R01 · FY2014 · HL · contact PI
Lymphatic Microenvironment: Altering Cell Traffic by Targeting Glycans$286,052
R01 · FY2013 · HL · contact PI
Lymphatic Microenvironment: Altering Cell Traffic by Targeting Glycans$300,475
R01 · FY2012 · HL · contact PI
Glycosaminoglycans and Cell Traffic in the Lymphatic Microenvironment$0
I01 · FY2012 · VA · contact PI
Glycosaminoglycans and Cell Traffic in the Lymphatic Microenvironment$0
I01 · FY2011 · VA · contact PI